NCT06880692 The Tick App: Changing Behaviors With Educational Messaging
| NCT ID | NCT06880692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Tick Bites |
| Study Type | INTERVENTIONAL |
| Enrollment | 40,000 participants |
| Start Date | 2020-03-31 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40,000 participants in total. It began in 2020-03-31 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this work is to evaluate the use of ecological momentary assessments as a tool to assess risk and risk factors for tick encounters and tick-borne diseases. This study will be conducted across the United States, with a focus the upper Midwest and Northeast and with a focus on Wisconsin and will enroll up to 1000 people.
Eligibility Criteria
Inclusion Criteria: * Will to participate in 7 days worth of daily activity logs within the Tick App. * be able and willing to provide informed consent Exclusion Criteria: * Completes less than 7 days worth of daily logs or completes 7+ daily logs but not within 12 months.
Contact & Investigator
Susan Paskewitz
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06880692 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tick Bites. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880692 currently recruiting?
Yes, NCT06880692 is actively recruiting participants. Contact the research team at chalvorsen2@wisc.edu for enrollment information.
Where is the NCT06880692 trial being conducted?
This trial is being conducted at Urbana, United States, East Lansing, United States, New York, United States, Pullman, United States.
Who is sponsoring the NCT06880692 clinical trial?
NCT06880692 is sponsored by University of Wisconsin, Madison. The principal investigator is Susan Paskewitz at University of Wisconsin, Madison. The trial plans to enroll 40,000 participants.